Trauma-adapted Yoga in Child & Adolescent Psychiatry.
Launched by UNIVERSITY WEST, SWEDEN · Mar 19, 2024
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of trauma-adapted yoga (TAY) on adolescents diagnosed with ADHD (Attention-Deficit/Hyperactivity Disorder) and/or PTSD (Post-Traumatic Stress Disorder). The researchers want to find out if TAY can help improve mental health, quality of life, and self-control for these young people. The trial will also look at how easy it is for participants to continue practicing yoga online and gather feedback from both the adolescents and their parents about their experiences. Additionally, healthcare professionals will share their thoughts on how TAY could fit into regular treatment.
To be eligible for this trial, participants should be between the ages of 14 and 18, have a confirmed diagnosis of ADHD and/or PTSD, and be able to understand either English or Swedish. However, those currently using substances, experiencing manic episodes, having psychotic disorders, or facing certain other medical issues may not be able to participate. If you or someone you know is interested in joining this study, participants can expect to take part in yoga sessions while receiving standard care, and their progress will be compared to a group that is on a waiting list for yoga.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adolescents who have received a diagnosis (not under evaluation) of PTSD and/or ADHD
- • Understanding English or Swedish languages.
- Exclusion Criteria:
- • Ongoing substance use,
- • active manic periods,
- • psychotic disorders,
- • suicidality,
- • cognitive impairment.
- • serious physical illness prohibiting participation in physical activities.
About University West, Sweden
University West, located in Sweden, is a leading academic institution dedicated to advancing research and education across various disciplines. With a strong emphasis on applied sciences, University West fosters innovation and collaboration through its extensive network of partnerships with industry and healthcare organizations. The university is committed to conducting high-quality clinical trials that contribute to the development of new therapies and enhance patient care. Its multidisciplinary approach ensures that research findings are grounded in practical applications, ultimately benefiting both the scientific community and the broader public.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gothenburg, , Sweden
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported